Showing results (851-860 of 888) with videos related to
Sort By:
Pageof 89
Scientific Reports|February 9, 2022
Retinal vascular impairment in Wolfram syndrome: an optical coherence tomography angiography studyMarco Battista, Maria Lucia Cascavilla, Domenico Grosso, et al.Translational Vision Science & Technology|June 10, 2025
Machine Learning Applied to Visual Fields of Dominant Optic Atrophy PatientsCatarina P Coutinho, Ferdinando Zanchetta, Michele Carbonelli, et al.Ophthalmology. Retina|December 12, 2022
Incidence and Risk Factors of Visual Impairment in Patients with Angioid Streaks and Macular NeovascularizationMaria Vittoria Cicinelli, Edoardo Torrioli, Lamberto La Franca, et al.Investigative Ophthalmology & Visual Science|December 13, 2023
Association of Circulating Antiretinal Antibodies With Clinical Outcomes in Retinitis PigmentosaLorenzo Bianco, Alessandro Arrigo, Alessio Antropoli, et al.Journal of Clinical Medicine|July 25, 2019
The Effectiveness of 0.6% Povidone Iodine Eye Drops in Reducing the Conjunctival Bacterial Load and Needle Contamination in Patients Undergoing Anti-VEGF Intravitreal Injection: A Prospective, Randomized StudyMichele Reibaldi, Teresio Avitabile, Francesco Bandello, et al.Eye (London, England)|May 6, 2020
One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategyFrancesco Bandello, Marco Coassin, Antonio Di Zazzo, et al.Ophthalmology|February 4, 2018
Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study)João Figueira, Emily Fletcher, Pascale Massin, et al.American Journal of Ophthalmology|November 18, 2023
Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt ImplantationAlessandro Rabiolo, Rebecca Toscani, Matteo Sacchi, et al.Eye (London, England)|May 30, 2020
Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategyFrancesco Bandello, Marco Coassin, Antonio Di Zazzo, et al.Journal of Vitreoretinal Diseases|March 3, 2025
Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER StudyAshish Sharma, Frank G Holz, Nilesh Kumar, et al.Pageof 89